Program:

Monday, Oct 29,2007              

Inaugural Session

Speaker

09:00

Welcome Address

Prof. N.K.Ganguly, Director General, ICMR

09:10

Orientation to the Symposium

Dr. Altaf Lal, U.S. Embassy Health Attachι and HHS Regional Representative for South Asia

09:20

Introductory Remarks

Dr. V.S. Chauhan, Director, ICGEB

09:30

Inaugural Address

Dr. Mangla Rai, Secretary, DARE and DG, ICAR

09:40

Keynote Address

Dr. M.K. Bhan, Secretary, DBT

09:50

Presidential Address

Mr. Naresh Dayal, Secretary, MOH

10:05

Vote of thanks

Dr. S.K. Bhattacharya, Additional DG, ICMR

10:10– 10:30

Break

 

 

Plenary Session : Avian Influenza: Threat to Human Health

Chairs: Prof. M. K. Bhan and Mr. V. Chawdhry

Rapporteur: Dr. U.C. Chaturvedi

10:30 – 11:00

N. K. Ganguly, DG, ICMR,  ND

Avian Influenza: Science, Policies and Issues

11:00 – 11:30

Nancy Cox, CDC, Atlanta, USA

Global Threat of AI: Can We Predict and Prevent Pandemic

 

Session 1: Animal Human Interface

Chairs: Dr. H.K. Pradhan and Dr. J. Katz

Rapporteur: Dr. D. A. Gadkari

11:30 – 12:00

Vineet Chawdhry, Joint Sec., MOH, New Delhi

Effective Coordination/Control Strategies and Preparedness Plans for AI in India: Human perspective

12:00 – 12:30

David Suarez, USDA,  Athens, USA

Animal Influenza Control: Surveillance, Diagnostics and Vaccines

12:30 – 13:00

A.C. Mishra, NIV, Pune

Characteristics of Indian Avian Influenza Isolates

13:00 - 14:00

Lunch

 

 

Session 2:  Zoonosis: What Drives the Adaptation

Chairs: Dr. Lal Krishna and Dr. David Suarez

Rapporteur: Dr. S. Lal

14:00 – 14:30

Erich Hoffmann, St. Judes, Memphis, USA

Molecular Determinants of Virulence and Transmission of H5N1 Influenza Viruses  

14:30 – 15:00

Prasert Auewarakul,   Bangkok, Thailand

Determinants of Receptor Specificity of H5: The Viral Adaptation to Human Host

15:00 – 15:30

Jacqueline Katz, CDC, Atlanta, USA

Serological Studies at the Animal-Human Interface

15:30 – 15:45

Tea Break

 

 

Session 3: Multi-lateral and Bilateral Collaborations

Chairs: Dr. S. Habayeb and Dr. Altaf Lal

Rapporteur: Dr. N. Sen

15:45 – 16:00

Jai Narain, WHO-SEARO, India

WHO-India Collaborations

16:00 – 16:15

M. Oberoi, Nepal

FAO-India Collaborations

16:15 – 16:30

R. Lal, CDC, Atlanta

U.S.-CDC-India Collaborations

16:30 – 16:45

Linda Lambert, NIH, Bethesda

U.S.-NIH-India Collaborations

16:45 – 17:00

Kεrstein Mεseide, Norway

Norwegian-Indian Bilateral Collaborations

19:30

Dinner hosted by ICMR

India Habitat Center

 

Tuesday, Oct 30, 2007

Plenary Session 2: Influenza Control Options

Chairs: Dr. R. K. Shrivastava and Dr. Shiv Lal

Rapporteur: Dr. U.C. Chaturvedi

09:00 – 09:30

Yoshihiro Kawaoka, Japan

Pandemic Influenza: Past and Future

09:30 – 10:00

Fred Hayden, Charlottesville, USA

Therapeutic Strategies: Anti Virals for Pandemic Influenza 

10:00 – 10:30

Suryaprakash Sambhara, CDC, Atlanta, USA

Global Overview of H5 Vaccine Development and Vaccine Platforms, Technologies and Future Directions

10:30 – 10:45

Tea Break

 

 

Session 4: Basic Biology and Pathogenesis

Chairs: Dr. A.C. Mishra and Dr. R. Donis

Rapporteur: Dr. D. A. Gadkari

10:45 – 11:05

R. Holland Cheng, University of California

Focus on Mechanisms of Viral Genome Packaging for Drug Targeting

11:05 – 11:25

Sunil Lal, ICGEB

Host-Virus Interactions of H5N1 Virus

11:25 – 11:45

Joshy Jacob, EVRC, Atlanta,

Cellular Dynamics of  Secondary Antibody Responses

11:45 – 12:00

Yee-Joo Tan, (IMCB), Singapore

Generation of H5N1 Monoclonal Antibodies for Therapeutic and Diagnostic Applications

 

Session 5: Diagnostics and Clinical Management of Avian Influenza

Chairs: Dr. D. Mukherjee and Dr. S. Broor

Rapporteur: Dr. G. Gunasekaran

12:00 – 12:20

John Nicholls, Hongkong

Pathogenesis of H5N1 in Human

12:20 – 12:40

Surender Khurana, FDA

Identification of Serological Epitopes of Avian Influenza for Diagnostic and Vaccine Development

12:40 – 13:00

Larisa Gubareva, CDC

Drug Resistance Monitoring: Advances and Challenges

13:00 – 14:00

Lunch Break

 

 

Session 6: Avian Influenza Vaccine and Pandemic Vaccines

Chairs: Dr. V. S. Chauhan and Dr. L. Lambert

Rapporteur: Dr. A. K. Prasad

14:00 – 14:30

Linda Lambert, NIH, Bethesda

Inactivated Pandemic Influenza Vaccine Development

14:30 – 15:00

Kanta Subbarao, NIH, Bethesda

Live Attenuated Pandemic Influenza Vaccines  

15:00 – 15:30

Ruben Donis, CDC, Atlanta, USA

Reverse Genetics Modified Derivation of High Growth Reassortents for Inactivated Pandemic Vaccines

15:30 – 15:45

Tea Break

 

 

Session 6 (contd): Avian Influenza Vaccine and Pandemic Vaccines

Chairs: Dr. R. R. Chaudhury and Dr. Kanta Subbarao

Rapporteur: Dr. S. K. Lal

15:45 – 16:05

Lars R. Haaheim, Bergen, Norway

Vaccines for an Influenza Pandemic: Scientific and Political Challenges

16:05 – 16:25

Aloke Chakraborty: NIV, Pune

Reverse Genetics Modified Indian H5N1

16:25 – 16:45

Agnete B. Fredriksen, Oslo, Norway

Vaccibodies: Potent Vaccine Molecules that Target Influenza Antigens to Antigen Presenting Cells

16:45 – 17:05

Rune Kjeken, Inovio Biomedical, Norway

Enhancing pDNA Vaccines by In Vivo Electroporation; a Small Shock Can go a Long Way

19:30 -

Dinner hosted by ICGEB

Hotel Claridges

 

Wednesday, Oct 31, 2007

Plenary Session 3: Surveillance for Avian Influenza:

Chairs: S.K. Bhattacharya and Dr. M.D. Gupte

Rapporteur: Dr. A. Gadkari

09:00 – 09:30

A. C. Mishra, NIV, Pune

Current and Future Influenza Surveillance Network in India

09:30 – 10:00

S.K. Bandopadhyay, DAHDF, New Delhi

Surveillance Tools for H5N1 in Poultry in India

10:00 – 10:30

T. Mundkur, FAO, Rome

Wild Bird Surveillance and Vulnerability Mapping  in India

 

T. Uyeki, CDC, Atlanta, USA

Clinical Characteristics of Human H5N1 Cases

10:30 – 10:45

Tea

 

 

Session 7: Molecular Epidemiology and Movements of Viruses

Chairs: Dr. C. M. Gupta  and Dr. S.K. Bandopadhyay

Rapporteur: Dr. M. Chawla-Sarkar

10:45 – 11:30

Ruben Donis, CDC, Atlanta, USA

Genetic Evolution of Avian Influenza Viruses

11:30 – 12:00

S. C. Dubey, HSADL, Bhopal

Prevalence, Pathogenic Potential and Genetic Analysis of AI Viruses Isolated in India

12:00 – 12:30

S. Cherian, NIV, Pune

Selection Pressure Analyses of the Genes of AI A (H5N1) Genotype Z Viruses

12:30 – 13:00

Colin Russell, UK

Global Patterns in the Evolution and Epidemiology of Influenza Viruses

13:00 – 14:00

Lunch

 

 

Session 8: Epidemiology and Surveillance of Avian Influenza

Chairs: Dr. U.C. Chaturvedi and Dr. H. Kaur

Rapporteur: Dr. P. Gunasekaran

14:00 – 14:20

Mandeep Chadha: NIV, Pune

Viral Characteristics of Seasonal Influenza Network in India.

14:20 – 14:40

Li Xin, Beijing, China

Surveillance of Avian Influenza A (H5N1) Viruses in Mainland China

14:40 – 15:00

Wallace Bulimo/ Kariuki Njenga, Kenya

Influenza Surveillance and Subtyping in Kenya, 2006-07

15:00 – 15:20

D. Naidoo,  Influenza Center, S. Africa

Influenza Surveillance in South Africa 

15:20 – 15:40

S. Pawar, NIV, Pune

Neutralizing Antibodies as Surveillance Tool for H5N1

15:40 – 16:00

Vinod. Scaria, IGIB

MicroRNAs in Antiviral Defense Against Influenza A/H5N1 Virus

16:00 – 16:20

Espen Rimstad, Norway

Risk Analysis of Introduction of HPAI Infections to Norway

16:20 – 16:40

Christine M. Jonassen, Norway

Surveillance of AI viruses in Birds in Norway

16:40 – 17:00

Harprasad N, Mumbai

A New Ligand as an Inhibitor of N1 Neuraminidase of H5N1 Avian Viruses

17:00 – 17:15         

 Sunil Lal                                     Adjourn and Vote of thanks